Public disclosures
Page built 2026-09-29
Data as of 2026-09-29
Search

Amylyx Pharmaceuticals Inc (AMLX): Congress and insider trades

Who in Congress and inside the company traded AMLX, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Amylyx Pharmaceuticals Inc (AMLX) is a listed stock on NASDAQ.
  • 1 member of Congress filed 1 buy and 0 sells of AMLX, the latest published 2022-11-17 (17 November 2022).
  • Insiders filed 1 open market buy worth $51.3K and 6 sells worth $2.5M, the latest filed 2026-09-14 (14 September 2026).
  • Across 1 scored buy, Congress averaged -2.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
  • Across 1 scored buy, Insiders averaged +163.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 1 1 members
Congress sells 0
Insider buys 1 $51.3K
Insider sells 6 $2.5M
Congress buys vs S&P, 90d -2.9% 1 scored buys
Insider buys vs S&P, 90d +163.9% 1 scored buys

Congress trades in AMLX

as of 2022-11-17
  1. Chris Jacobs1 trade
Congress trades in AMLX, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
17 Nov 2022 Chris Jacobs (R-NY) buy 1K–15K 35 -2.9%

Insider trades in AMLX

as of 2026-09-14
Open market insider trades in AMLX, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
14 Sep 2026 Klee Justin B. sell 30,464 $32.18 $980K n/a
14 Sep 2026 FRATES JAMES M sell 10,810 $32.36 $350K n/a
14 Sep 2026 Mazzariello Gina sell 9,536 $32.46 $310K n/a
14 Sep 2026 Bedrosian Camille L sell 10,028 $32.40 $325K n/a
13 Jul 2026 Mazzariello Gina sell 15,000 $17.61 $264K n/a
13 Jul 2026 Mazzariello Gina sell 15,000 $18.32 $275K n/a
26 May 2026 Firestone Karen buy 3,800 $13.51 $51.3K +163.9%

Frequently asked questions

Who has bought AMLX?

1 Congress buy by 1 member and 1 insider buy are on file. The tables on this page list every one.

Did buying AMLX after a disclosure beat the market?

Across 1 scored buy, Congress averaged -2.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. Across 1 scored buy, Insiders averaged +163.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.